Research led by UNC’s Kathleen Caron, PhD, shows that halting the protein CXCR7 leads to over activation of adrenomedullin, a hormone needed at proper levels for normal cardiovascular development
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed an ultrasound device that could help identify arterial plaque that is at high risk of breaking off and causing heart attack or stroke.
UNC’s William Powers, MD, provides the first hard evidence for how to treat stroke patients with poor collateral blood vessel formation.
The UNC Center for Heart and Vascular Care collaborates with specialists in the Raleigh area to provide care for the most complex heart cases. (This feature was originally published in UNC Health Care's Well Magazine, Winter 2014 issue)
A North Carolina nonprofit organization and a UNC Hospitals volunteer partnered to bring an 8-year-old girl with congenital heart problems to UNC for medical treatment.
A new study by UNC researchers finds that patients who suffer a STEMI heart attack while hospitalized are 10 times more likely to die than patients who suffer a STEMI outside the hospital.
On Monday, June 18, 2012, the UNC Center for Heart & Vascular Care’s Aortic Disease Management team became the first in the U.S. to successfully treat a complex abdominal aortic aneurysm (AAA) with the Zenith® Fenestrated AAA Endovascular Graft.
Cardiology, Heart Health, Innovation, Technology, Treatment, Vascular Health
A study led by researchers from the University of North Carolina at Chapel Hill School of Medicine has identified a molecular pathway that leads to the formation of abnormal blood clots. They turned it off using a popular class of cholesterol-lowering drugs, statins.
Cardiology, Innovation, Research, Studies, Treatment, Vascular Health
Researchers have long sought ways to avoid scarring of the heart after a heart attack. But now new research from the University of North Carolina at Chapel Hill School of Medicine shows that interrupting this process can weaken heart function even further.
The study, which began in August 2010 and will be conducted entirely at UNC, seeks to enroll a total of 320 women ages 45 to 55 who are in the menopause transition. All will be randomized to receive treatment with estradiol (estrogen replacement) skin patches or placebo.
Hugh “Chip” McAllister, M.D., an alumnus of the University of North Carolina at Chapel Hill School of Medicine, has made a three-part gift to establish the UNC McAllister Heart Institute.
